Davis Todd C bought LGND
June 30, 2026 · Form 4 insider transaction
Davis Todd C bought 132 shares of Ligand Pharmaceuticals Incorporated at $160.71 per share, a transaction worth $21.2K. The trade was recorded as j and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
132
Price
$160.71
Total value
$21.2K
InsiderDavis Todd C
Role—
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJune 30, 2026
Filing dateJuly 6, 2026
Shares owned after199,513
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).